These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 30387870)

  • 1. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
    Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
    Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
    An Y; Liang J; Schild SE; Bues M; Liu W
    Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
    Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
    Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel fast robust optimization algorithm for intensity-modulated proton therapy with minimum monitor unit constraint.
    Fan Q; Zhao L; Li X; Hu J; Lu X; Yang Z; Zhang S; Yang K; Ding X; Liu G; Dai S
    Med Phys; 2024 Sep; 51(9):6220-6230. PubMed ID: 38967477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Including robustness in multi-criteria optimization for intensity-modulated proton therapy.
    Chen W; Unkelbach J; Trofimov A; Madden T; Kooy H; Bortfeld T; Craft D
    Phys Med Biol; 2012 Feb; 57(3):591-608. PubMed ID: 22222720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust optimization of intensity modulated proton therapy.
    Liu W; Zhang X; Li Y; Mohan R
    Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
    Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
    Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust optimization in IMPT using quadratic objective functions to account for the minimum MU constraint.
    Shan J; An Y; Bues M; Schild SE; Liu W
    Med Phys; 2018 Jan; 45(1):460-469. PubMed ID: 29148570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.
    Liu W; Li Y; Li X; Cao W; Zhang X
    Med Phys; 2012 Jun; 39(6):3089-101. PubMed ID: 22755694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
    Liu W; Liao Z; Schild SE; Liu Z; Li H; Li Y; Park PC; Li X; Stoker J; Shen J; Keole S; Anand A; Fatyga M; Dong L; Sahoo N; Vora S; Wong W; Zhu XR; Bues M; Mohan R
    Pract Radiat Oncol; 2015; 5(2):e77-86. PubMed ID: 25413400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust beam orientation optimization for intensity-modulated proton therapy.
    Gu W; Neph R; Ruan D; Zou W; Dong L; Sheng K
    Med Phys; 2019 Aug; 46(8):3356-3370. PubMed ID: 31169917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated proton treatment planning with robust optimization using constrained hierarchical optimization.
    Taasti VT; Hong L; Deasy JO; Zarepisheh M
    Med Phys; 2020 Jul; 47(7):2779-2790. PubMed ID: 32196679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.